Published Date : Jun 14, 2016
ALBANY, NY, June 14, 2016: MarketResearchReports.biz recently announced the inclusion of a new market research study, titled “European HIV/AIDS Testing Industry 2016 Market Research Report,” to its comprehensive collection of research reports. The report has presented the statistics of the HIV/AIDS testing industry in Europe with the help of 149 tables and figures and provides direction and guidance to individuals and companies interested in the industry.
The research study further offers scientific views on the definition, etiology, and epidemiology of AIDS and other related retroviruses. It evaluates the market applications of molecular diagnostics, IT, immunodiagnostics, and other developing technologies in the European HIV/AIDS testing industry. Moreover, the research report studies the infectious disease testing analyzers marketed by the major players and other suppliers in the overall market. The alternative market penetration policies for suppliers have also been included in the scope of the report.
HIV/AIDS refers to a chronic disease that is caused by the human immunodeficiency virus. This virus harms the human immune system, leading to loss of ability to fight with organisms and weakness of the immune system. HIV/AIDS mostly spreads through unprotected sex with a person who is HIV-infected. It can also be passed on from an infected mother to her child during pregnancy or from the sharing of needles with a person who has HIV/AIDS condition. Some of the key diagnosis for HIV/AIDS are HIV home-testing kit, HIV antibody assay, polymerase chain reaction test, antigen-antibody immunoassay, western blot, HIV p24 antigen test, and rapid HIV antibody test.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/724980
The rising number of HIV/AIDS patients, growing incidences of infectious diseases, and technological developments in the diagnosis of HIV/AIDS are the key factors projected to stimulate the growth of the European HIV/AIDS testing industry in the next few years. In addition, the lack of awareness regarding the different modes of transmission of the virus could potentially cause a rise in the number of people infected, thus creating the need for more HIV testing products. The increasing research and development activities are anticipated to propel the HIV/AIDS testing industry in Europe throughout the forecast period.
Moreover, several government initiatives in order to create awareness regarding HIV/AIDS and the cost-effective drug therapies and other treatments available in the market. These factors are estimated to drive the HIV/AIDS testing industry in the near future. On the other hand, patient protection losses and rapid replacement of HIV/AIDS drugs and therapies by several new drugs and therapies are the key factors anticipated to curtail the growth of the HIV/AIDS testing industry in Europe.
The research report offers an in-depth vendor reports of the European HIV/AIDS testing industry and throws light on the competitive landscape of the market. Some of the prominent players operating in the European HIV/AIDS testing industry are BioMerieux, Adaltis, Alere, Beckman Coulter, and Abbott Laboratories. To provide a clear understanding, the research study includes detailed profiles of the leading players, focusing on their product portfolio, business strategies, financial status, and recent developments and news if any.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com